Impact Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
11,635
+58
+0.5% +$6.79K 0.41% 64
2026
Q1
$1.39M Buy
11,577
+40
+0.3% +$4.62K 0.42% 57
2025
Q4
$1.21M Sell
11,537
-7
-0.1% -$657 0.36% 60
2025
Q3
$969K Buy
11,544
+485
+4% +$39.9K 0.29% 70
2025
Q2
$875K Sell
11,059
-136
-1% -$10.8K 0.29% 80
2025
Q1
$1M Sell
11,195
-167
-1% -$15.6K 0.36% 68
2024
Q4
$1.13M Buy
+11,362
New +$1.17M 0.4% 60

Other funds holding MRK

Impact Capital Partners's MRK Position: Q2 2026 in Review

Impact Capital Partners increased its Merck (MRK) stake by 0.5% in Q2 2026, buying an estimated $6.79K and bringing the position to 11,635 shares worth $1.5M. The position accounts for 0.41% of the portfolio, ranked #64.

Impact Capital Partners first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 993 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Impact Capital Partners held 11,635 shares of Merck worth $1.5M as of Q2 2026.
  • Impact Capital Partners bought 58 Merck shares in Q2 2026, an estimated $6.79K.
  • Merck made up 0.41% of Impact Capital Partners's portfolio in Q2 2026, its #64 holding.
  • Impact Capital Partners first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 993 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Impact Capital Partners's 13F filing for Q2 2026, filed 14 Jul 2026.